PG

Priti Gehlot

Active Director Director DIN 10406030
DIN 10406030 First appointment Nov 2023 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Nov 2023
Shareholding value Locked Premium profile

About Priti Gehlot

Priti Gehlot has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Argentos Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10406030
Primary Designation Director
First Appointment 28 Nov 2023
Oldest Company Age 2 yrs

Current companies

Company Designation Appointment Founded Status
Argentos Pharma Private Limited U32500DL2023PTC423133
Director 28 Nov 2023 2023 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Argentos Pharma Private Limited
Premium access

Shareholding and investment profile for Priti Gehlot

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priti Gehlot

Priti Gehlot has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Argentos Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Priti Gehlot is associated with 1 company as Director.

Priti Gehlot has expertise in General Business.

Priti Gehlot has 2 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available